not tagged
not tagged
['urothelial']
at #esmo2022, shared results from a phase 1/2 trial of a new drug combination for people with locally advanced or metastatic urothelial cancer. these drugs shrank tumors in 64.5% of patients, and 10.5% saw tumors disappear completely. 
The official account of @MSKCancerCenter’s Department of Medicine. Chair/Dept head @debschrag